Bets in Rapid DX
Quidel Corp. wants to become a consolidator of rapid diagnostics companies and products. The timing is right: just as big companies focused on the central laboratory are consolidating, opportunities abound in the rapid testing market, which has too many small competitors lacking critical mass and adequate distribution.
You may also be interested in...
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
MeMed has received CE Marking for its diagnostic test MeMed BV and point-of-need platform MeMed Key, which uses the human immune system to distinguish between bacterial and viral infections to prevent antibiotic overuse.
The latest global vaccines summit has seen the launch of a new mechanism designed to spur the development of new coronavirus vaccines and ensure they are made available, particularly in low- and middle-income countries.